back room discussions indicate excellent sales figures, await further Co notices.
"excellent news for GroPep, who we believe supply their proprietary LR3 growth factor as a key ingredient in the manufacture of Enbrel. 4Q CY04 sales of Enbrel by Wyeth were US$216 million, up a staggering 25% on 3Q CY04 sales, with 4Q sales by Amgen of US$567 million, up 14% on the previous quarter."
Do your own research.